Recombinant AAV Viral Vectors Pseudotyped with Viral Capsids from Serotypes 1, 2, and 5 Display Differential Efficiency and Cell Tropism after Delivery to Different Regions of the Central Nervous System

This publication has 89 references indexed in Scilit:

• Recombinant AAV-mediated gene delivery to the central nervous system
  The Journal of Gene Medicine, 2004
• Use of adeno-associated viral vector for delivery of small interfering RNA
  Oncogene, 2003
• Selective gene expression in brain microglia mediated via adeno-associated virus type 2 and type 5 vectors
  Gene Therapy, 2003
• Uniform Long-Term Gene Expression using Adeno-Associated Virus (AAV) by Ex Vivo Recirculation in Rat-Cardiac Isografts
  The Thoracic and Cardiovascular Surgeon, 2002
• CMV-β-Actin Promoter Directs Higher Expression from an Adeno-Associated Viral Vector in the Liver than the Cytomegalovirus or Elongation Factor 1α Promoter and Results in Therapeutic Levels of Human Factor X in Mice
  Human Gene Therapy, 2001
• Recombinant Adeno-associated Viral Vector-Mediated Glial Cell Line-Derived Neurotrophic Factor Gene Transfer Protects Nigral Dopamine Neurons after Onset of Progressive Degeneration in a Rat Model of Parkinson's Disease
  Experimental Neurology, 1999
• Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield
  Gene Therapy, 1999
• Adeno-Associated Virus-Mediated Gene Transfer to the Brain: Duration and Modulation of Expression
  Human Gene Therapy, 1999
• Selective and Rapid Uptake of Adeno-Associated Virus Type 2 in Brain
  Human Gene Therapy, 1998
• Neuron-Specific Transduction in the Rat Septohippocampal or Nigrostriatal Pathway by Recombinant Adeno-associated Virus Vectors
  Experimental Neurology, 1998